Li-Fraumeni Syndrome/TP53 Biobank
Clinical trial NCT04367246 · RECRUITING
Trial details
- NCT number
- NCT04367246
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-24
- Primary completion
- 2029-09-24
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.